
|Articles|May 1, 2006
- Volume 0 0
MISSISSIPPI BILL SPEEDS UP PHARMACY REIMBURSEMENT
Advertisement
The passing of Mississippi House Bill 542 was met withpraise from the National Community PharmacistsAssociation. The law includes provisions to guaranteeprompt payment of health insurance claims to pharmacistsby pharmacy benefit managers (PBMs). The legislation,which goes into effect on June 30, 2006, amends theMississippi Pharmacy Practice Act. It will require thatPBMs do the following:
- File financial statements with the state insurancedepartment
- Use a nationally recognized reference in pricing calculationswhen reimbursing pharmacies and updatethat reference no less than every 3 business days
- Pay clean claims that are filed electronically within 15days (paper claims no later than 35 days)
The Board of Pharmacy will monitor PBMs for compliancewith the law and has the power to subject them toadministrative penalties for noncompliance.
Articles in this issue
over 20 years ago
A Good Night's Rest—Helping the Patient with Insomniaover 20 years ago
Is Sleep-Driving for Real?over 20 years ago
Painful Diabetic Neuropathy: Alternative Treatmentsover 20 years ago
A New Day Dawns for NCPA and NACDSover 20 years ago
compounding HOTLINEover 20 years ago
RESPy AWARDover 20 years ago
ULM STUDENT NEEDED TO HELPover 20 years ago
Must an Embezzling Pharmacist Repay Wages Received?over 20 years ago
Web-based Program Aids Health Care Industryover 20 years ago
Depression: Identifying Symptoms and Appropriate TreatmentAdvertisement
Related to this article

Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.

A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.

Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.

The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5



